Rivaroxaban Terminated Phase 1 Trials for Gastric Bypass Status Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02058199Rivaroxaban Effects in Subjects Who Have Undergone Gastric Bypass Surgery